| Trial ID: | L1251 |
| Source ID: | NCT00893451
|
| Associated Drug: |
Cholecalciferol (Tillval-D)
|
| Title: |
Study of Vitamin D3 Supplementation in Patients With Chronic Kidney Disease
|
| Acronym: |
VitaD-CKD1
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Insulin Resistance|Vitamin D Deficiency
|
| Interventions: |
DRUG: cholecalciferol (TillVal-D)|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in M-value (mg/kg lean body mass/min) assessed by insulin-glucose clamp, at week 26 | Secondary: Change in systolic- and diastolic blood pressure, at week 26|Change in PTH secretion and its fragments assessed by PTH, CAP-PTH, CIP-PTH, at week 26|Change in insulin secretion assessed by intravenous glucose tolerance test, at week 26|Change in urinary excretion of albumin (UAE) assessed by 24 hour collection, at week 26
|
| Sponsor/Collaborators: |
Sponsor: Sahlgrenska University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-09
|
| Completion Date: |
2011-06
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-10
|
| Locations: |
Department of Kidney diseases, Sahlgrenska University Hospital, Gothenburg, 41345, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT00893451
|
